Insider Transactions in Q1 2024 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-1.35%
|
$45,000
$30.95 P/Share
|
|
Mar 18
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,914
-2.05%
|
$90,334
$31.58 P/Share
|
|
Mar 18
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,123
-0.78%
|
$65,813
$31.58 P/Share
|
|
Mar 18
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,252
-2.19%
|
$38,812
$31.58 P/Share
|
|
Mar 18
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,261
-1.22%
|
$39,091
$31.58 P/Share
|
|
Mar 18
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,788
-1.24%
|
$179,428
$31.58 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,936
-5.28%
|
$269,824
$34.07 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,936
+5.01%
|
$31,744
$4.09 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,735
-9.95%
|
$534,990
$34.02 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,735
+9.05%
|
$62,940
$4.09 P/Share
|
|
Mar 01
2024
|
Mark A Goldsmith |
SELL
Grant, award, or other acquisition
|
Direct |
90,000
-16.18%
|
-
|
|
Mar 01
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+22.35%
|
-
|
|
Mar 01
2024
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
24,200
+22.26%
|
-
|
|
Mar 01
2024
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,400
+20.37%
|
-
|
|
Mar 01
2024
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
51,400
+15.84%
|
-
|
|
Mar 01
2024
|
Jeff Cislini General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+26.88%
|
-
|
|
Jan 22
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.99%
|
$40,500
$27.0 P/Share
|
|
Jan 08
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,337
-1.48%
|
$96,773
$29.01 P/Share
|
|
Jan 02
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
13,330
-5.59%
|
$386,570
$29.1 P/Share
|